Clinical Trial Update: Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update evaluating chidamide, an HDAC inhibitor, as targeted therapy for adult early T-cell precursor acute lymphoblastic leukemia (ET…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• T-cell Acute Lymphoblastic Leukemia
• T-cell Precursor Leukemia

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Leukemia, Acute, Leukemia, T Cell | Phase 2, Phase 3 | Status: UNKNOWN